Evusheld is a combination of two long-acting monoclonal antibodies and is the only antibody therapy authorised in the US to prevent Covid-19
The company plans to expand their capacity to meet the needs of pharma and biotech industries
Healtherbs helps in restoring the desired energy levels for daily activity and immunity
_256_384.jpg)
Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.
He has more than 285 publications with 7,600 citations, 80 students have already been awarded Ph. D. degree under his able guidance and 20 postdoctoral associates have worked in his group
Sputnik M is a new member of the Sputnik vaccines family
The investigational compound, GZR18, is a novel analogue of glucagon-like peptide-1 (GLP-1), an incretin hormone responsible for many glucoregulatory effects
The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
The fund aims at investing in companies that extends human healthspan
Subscribe To Our Newsletter & Stay Updated
